These data imply a limitation of the current study that nuclear HDAC activity and cytoplasmic TNFa levels in synovial tissues from RA patients can be affected by medical treatments with DMARDs or corticosteroid. This evidence concerns the gene HDAC9 and rheumatoid arthritis.